Actively Recruiting
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
Led by University of Pittsburgh · Updated on 2026-02-17
400
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Pittsburgh
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying a new patient-centered tool called MyPath designed to help women with substance use disorders (SUDs) make better decisions about contraception after giving birth. Women with SUDs often face challenges such as unintended pregnancies and rapid repeat pregnancies. This study aims to improve postpartum contraceptive choices by supporting women in aligning decisions with their reproductive goals and health needs. Participants are randomly assigned to one of two groups. One group uses the MyPath decision support tool during their first visit postpartum, which helps women consider their feelings about pregnancy, learn about fertility, and prioritize contraceptive method preferences. The other group receives the usual contraceptive counseling provided by healthcare staff. The study compares these approaches to see how they affect contraceptive use and decision quality. Women in the study will be followed from delivery up to 18 months afterward, with assessments of contraceptive use, decision-making quality, and pregnancy outcomes. Researchers will collect information on contraceptive continuation, effectiveness, unintended pregnancies, and intervals between pregnancies. Data will also be gathered on knowledge, values alignment, decisional conflict, and involvement in contraceptive decisions. The study includes interviews with patients, providers, and health systems to explore how MyPath could be integrated into postpartum care if effective.
CONDITIONS
Brief Title
Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum Period
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be female and at least 18 years old.
- Be pregnant with an estimated gestational age of 22 to 37 weeks at enrollment or be 0 to 9 days postpartum at enrollment.
- Plan to deliver or have delivered at the research site.
- Meet criteria for a substance use disorder (opioid, stimulant, or other) or have a related diagnosis in medical records.
You will not qualify if you...
- Have experienced a fetal or neonatal death with the current pregnancy.
- Be currently in jail or prison as required by law (probation or residential facilities do not exclude).
- Have any condition that the investigator believes would make participation unsafe, difficult, or complicate data interpretation.
- For postpartum participants only: have documented tubal ligation or hysterectomy at delivery hospitalization.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Duration - Immediate postpartum period (during hospital stay)
Participants receive the MyPath decision tool or standard contraceptive counseling immediately postpartum to support contraceptive decision-making.
1 visit (in-person) at delivery hospitalization
Duration - Up to 18 months post delivery
Participants continue to utilize contraceptive methods and their decision quality is supported and assessed up to 18 months after delivery.
Regular follow-up visits during the 18 months postpartum period
Trial Site Locations
Total: 1 location
1
Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
E
Elizabeth Krans, MD
S
Samantha Mayo, BA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here